| Product NDC: | 0187-0140 | 
| Proprietary Name: | Vasotec | 
| Non Proprietary Name: | Enalapril Maleate | 
| Active Ingredient(s): | 2.5 mg/1 & nbsp; Enalapril Maleate | 
| Administration Route(s): | ORAL | 
| Dosage Form(s): | TABLET | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 0187-0140 | 
| Labeler Name: | Valeant Pharmaceuticals North America LLC | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | NDA018998 | 
| Marketing Category: | NDA | 
| Start Marketing Date: | 19880726 | 
| Package NDC: | 0187-0140-90 | 
| Package Description: | 90 TABLET in 1 BOTTLE (0187-0140-90) | 
| NDC Code | 0187-0140-90 | 
| Proprietary Name | Vasotec | 
| Package Description | 90 TABLET in 1 BOTTLE (0187-0140-90) | 
| Product NDC | 0187-0140 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | Enalapril Maleate | 
| Dosage Form Name | TABLET | 
| Route Name | ORAL | 
| Start Marketing Date | 19880726 | 
| Marketing Category Name | NDA | 
| Labeler Name | Valeant Pharmaceuticals North America LLC | 
| Substance Name | ENALAPRIL MALEATE | 
| Strength Number | 2.5 | 
| Strength Unit | mg/1 | 
| Pharmaceutical Classes | Angiontensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],Decreased Blood Pressure [PE] |